The European Commission (EC), Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) have launched a collaboration to accelerate clinical research in Europe. The new initiative is called Accelerating Clinical Trials in the EU, or ACT-EU, and together with the launch of the Clinical Trials Information System (CTIS) on 31 January 2022, these programs aim to make the EU more attractive for clinical research by:
enabling innovative trial methods,
strengthening the coordination of clinical trial authorization across the EU, and
supporting the modernization of Good Clinical Practice (GCP).
In addition, the ACT EU initative will establish a multi-stakeholder platform that includes patients, allowing patients’ voices to be heard and to impact how clinical trials are designed and executed.